Clinical performance of a prefabricated immunofluorescence assay for nasopharyngeal cancer screening
Head & Neck · 2024
DOI: 10.1002/hed.27790 ↗Kurz gefasst
Fachartikel in der Zeitschrift Head & Neck, 2024. Verfasst von Vanessa Hui En Chen und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology - Head and Neck Surgery, National University of Singapore, Singapore. Hauptthemen laut MEDLINE: Nasopharyngeal Neoplasms, Early Detection of Cancer, Immunoglobulin A. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: National Medical Research Council, Singapore, National University of Singapore, National University Cancer Institute, Singapore.
Abstract (Originalsprache)
Background
Epstein–Barr virus (EBV) IgA serology for viral capsid antigen (VCA) and early antigen (EA) aids early detection of nasopharyngeal cancer (NPC), resulting in improved survival. We evaluated the diagnostic performance of a prefabricated immunofluorescent assay (IFA) for NPC screening in high‐risk individuals.
Methods
Sera from 96 biopsy‐proven patients with NPC diagnosed at the outpatient clinic and 96 healthy family members were tested for EBV‐VCA IgA and EBV‐EA IgA using the prefabricated IFA from EUROIMMUN (EI) and the traditional immunofluorescence method.
Results
The AUC of EI EBV‐VCA IgA and EBV‐EA IgA was 0.907 (95% confidence interval [CI]: 0.894–0.965) and 0.898 (95% CI: 0.848–0.947), respectively. Combined testing with the prefabricated assay at a threshold of VCA ≥1:320 or EA ≥1:10 showed 92.7% sensitivity and 81.2% specificity. Overall, the traditional EBV‐EA IgA assay demonstrated the best accuracy (sensitivity 91.7% and specificity 96.9%) at a threshold of ≥1:5.
Conclusion
While the traditional IFA method was more accurate, the prefabricated IFA test kit can be a useful tool for NPC screening in high‐risk populations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otolaryngology - Head and Neck Surgery, National University of Singapore, Singapore.
- Department of Otolaryngology - Head and Neck Surgery, National University Hospital, Singapore.
- Department of Laboratory Medicine, National University Hospital, Singapore.
- Pathnova Laboratories, Singapore.
- Temasek Life Sciences Laboratory, Singapore.
- Department of Biological Sciences, National University of Singapore, Singapore.
ORCID-Profile: Vanessa Hui En Chen, Donovan Eu, Joshua K Tay
Förderung
- National Medical Research Council, Singapore
- National University of Singapore
- National University Cancer Institute, Singapore
- Medical Research Council
- National Medical Research Council
Zitieren
APA
Chen, V. H. E., Ong, L., Teo, W. K., Siow, C. H., Goh, H. L., Tan, C., Lim, W. S., Eu, D., Cheong, I. S. Y., Chan, S. H., Loh, K. S., & Tay, J. K. (2024). Clinical performance of a prefabricated immunofluorescence assay for nasopharyngeal cancer screening. Head & Neck. https://doi.org/10.1002/hed.27790
Vancouver
Chen VHE, Ong L, Teo WK, Siow CH, Goh HL, Tan C, et al. Clinical performance of a prefabricated immunofluorescence assay for nasopharyngeal cancer screening. Head & Neck. 2024. doi:10.1002/hed.27790
BibTeX
@article{Chen2024,
author = {Chen, Vanessa Hui En and Ong, Lizhen and Teo, Wei Keat and Siow, Chor Hiang and Goh, Han Lee and Tan, Charmaine and Lim, Wei Sian and Eu, Donovan and Cheong, Ian S Y and Chan, Soh Ha and Loh, Kwok Seng and Tay, Joshua K},
title = {Clinical performance of a prefabricated immunofluorescence assay for nasopharyngeal cancer screening},
journal = {Head & Neck},
year = {2024},
doi = {10.1002/hed.27790}
}
EUVIMED